^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    universal chimeric antigen receptor-modified AT19 cells

    i
    Other names: universal chimeric antigen receptor-modified AT19 cells, CAR-NK-CD19 cells, AT19 cells
    Associations

    News

    Trials
    Company:
    Chengdu USino Techno, Wuhan Union Hospital
    Drug class:
    CD19 inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies (clinicaltrials.gov)
    P1, N=27, Recruiting, Wuhan Union Hospital, China
    Clinical • New P1 trial
    |
    CD19 (CD19 Molecule)
    |
    fludarabine IV • universal chimeric antigen receptor-modified AT19 cells